Yield10 Bioscience, Inc. (NASDAQ:YTEN – Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.27 and traded as high as $0.28. Yield10 Bioscience shares last traded at $0.27, with a volume of 276,391 shares.
Analysts Set New Price Targets
Separately, Lake Street Capital downgraded Yield10 Bioscience from a “buy” rating to a “hold” rating in a research report on Thursday, February 8th.
View Our Latest Report on YTEN
Yield10 Bioscience Trading Down 2.1 %
Institutional Investors Weigh In On Yield10 Bioscience
An institutional investor recently bought a new position in Yield10 Bioscience stock. Millennium Management LLC bought a new stake in shares of Yield10 Bioscience, Inc. (NASDAQ:YTEN – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 58,768 shares of the specialty chemicals company’s stock, valued at approximately $132,000. Millennium Management LLC owned 1.20% of Yield10 Bioscience as of its most recent SEC filing. 4.91% of the stock is currently owned by hedge funds and other institutional investors.
Yield10 Bioscience Company Profile
Yield10 Bioscience, Inc operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions.
Further Reading
- Five stocks we like better than Yield10 Bioscience
- Investing in Construction Stocks
- Comprehensive PepsiCo Stock Analysis
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for Yield10 Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yield10 Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.